CHANGES IN COGNITIVE STATUS AND NARCOLEPTIC SYNDROME IN POST-COVID-19 DISORDERS
Sokolova L.P.
For quotation:
Sokolova L.P. Changes in cognitive status and narcoleptic syndrome during post-Covid
disorders // Behavioral neurology. 2021. No. 2. pp. 40–46.
DOI 10.46393/2712-9675_2021_2_40_46
Annotation:
The article provides data on the causes, types and severity of cognitive impairment in the post-Covid period, treatment directions, including drug therapy and behavioral recommendations. Disorders of adaptation to stress and sleep disorders are separately considered as significant causes of cognitive decline in patients in the post-Covid period. The properties and benefits of choline alfoscerate (Cereton®), which is the drug of choice for the treatment of patients with pathologies of the central nervous system, as well as for patients
elderly people in the post-Covid period.
Journal "Behavioral Neuroscience" No. 2_2021
https://drive.google.com/file/d/1uCJ-UMtOZ4iweRqOvv7R3hE1ichAAmY6/view
Sokolova L.P.
For quotation:
Sokolova L.P. Changes in cognitive status and narcoleptic syndrome during post-Covid
disorders // Behavioral neurology. 2021. No. 2. pp. 40–46.
DOI 10.46393/2712-9675_2021_2_40_46
Annotation:
The article provides data on the causes, types and severity of cognitive impairment in the post-Covid period, treatment directions, including drug therapy and behavioral recommendations. Disorders of adaptation to stress and sleep disorders are separately considered as significant causes of cognitive decline in patients in the post-Covid period. The properties and benefits of choline alfoscerate (Cereton®), which is the drug of choice for the treatment of patients with pathologies of the central nervous system, as well as for patients
elderly people in the post-Covid period.
Journal "Behavioral Neuroscience" No. 2_2021
https://drive.google.com/file/d/1uCJ-UMtOZ4iweRqOvv7R3hE1ichAAmY6/view
